0001415889-21-004349.txt : 20210910 0001415889-21-004349.hdr.sgml : 20210910 20210910174253 ACCESSION NUMBER: 0001415889-21-004349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210908 FILED AS OF DATE: 20210910 DATE AS OF CHANGE: 20210910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAMPROPOULOS FRED P CENTRAL INDEX KEY: 0000901534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18592 FILM NUMBER: 211248000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000856982 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870447695 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1600 WEST MERIT PARK WAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 8012531600 MAIL ADDRESS: STREET 1: 1600 WEST MERIT PARKWAY CITY: SOUTH JORDAN STATE: UT ZIP: 84095 4 1 form4-09102021_020944.xml X0306 4 2021-09-08 0000856982 MERIT MEDICAL SYSTEMS INC MMSI 0000901534 LAMPROPOULOS FRED P 1600 WEST MERIT PARKWAY SOUTH JORDAN UT 84095 true true false false PRESIDENT AND CEO Common Stock, No Par Value 2021-09-08 4 M 0 5000 17.27 A 6269 I By spouse Common Stock, No Par Value 2021-09-08 4 F 0 2410 72.23 D 3859 I By spouse Common Stock, No Par Value 967916 D Common Stock, No Par Value 95919 I By 401(k) Plan Common Stock, No Par Value 90 I By spouse as custodian for child Non-qualified stock options (right to buy) 17.27 2021-09-08 4 M 0 5000 0 D 2016-02-13 2022-02-13 Common Stock 5000 0 I See footnote Non-qualified stock options (right to buy) 16.05 2017-01-28 2023-01-28 Common Stock 50000 50000 D Non-qualified stock options (right to buy) 16.05 2017-01-28 2023-01-28 Common Stock 6000 6000 I See footnote Non-qualified stock options (right to buy) 28.20 2018-04-14 2024-04-14 Common Stock 200000 200000 D Non-qualified stock options (right to buy) 28.20 2018-04-14 2024-04-14 Common Stock 6000 6000 I See footnote Non-qualified stock options (right to buy) 44.80 2019-03-02 2025-03-02 Common Stock 38002 38002 D Non-qualified stock options (right to buy) 44.80 2019-03-02 2025-03-02 Common Stock 4000 4000 I See footnote Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 159151 159151 D Non-qualified stock options (right to buy) 55.73 2020-03-01 2026-03-01 Common Stock 2000 2000 I See footnote Non-qualified stock options (right to buy) 37.71 2021-02-26 2027-02-26 Common Stock 100334 100334 D Non-qualified stock options (right to buy) 56.25 2022-03-19 2028-03-19 Common Stock 58083 58083 D Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Represents plan holdings as of 9/10/2021. Became exercisable in equal annual installments of 20% commencing 2/13/2016. Became exercisable in equal annual installments of 20% commencing 1/28/2017. Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited. Becomes exercisable in equal annual installments of 20% commencing 4/14/2018. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited. Becomes exercisable in equal annual installments of 20% commencing 3/2/2019. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited. Becomes exercisable in equal annual installments of 20% commencing 3/1/2020. Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited. Becomes exercisable in equal annual installments of 25% commencing 2/26/2021. Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. /s/ Brian G. Lloyd, Attorney-in-Fact 2021-09-10